Legal Representation
Attorney
Stacy L. Wu
USPTO Deadlines
Next Deadline
1338 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20230829)
Due Date
August 29, 2029
Grace Period Ends
February 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 20, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 9, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 9, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 9, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 9, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 9, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 23, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Sep 29, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 29, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 28, 2023 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Aug 29, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 13, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 24, 2023 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 6, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 4, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 30, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 29, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders
Class 010
Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders
Class 042
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
Class 044
Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
Classification
International Classes
005
010
042
044